Spaced Education to Optimize Prostate Cancer Screening
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Percentage of inappropriate prostate-specific antigen (PSA) screening performed by clinicians
The primary outcome measure was the difference in the percentage of inappropriate PSA screening performed by clinicians in the spaced education and control cohorts. Based on published clinical guidelines and reports, inappropriate PSA utilization was defined as the use of PSA for prostate cancer screening in patients >76 or <40 years old, or with an estimated life expectancy of less than 10 years.
B. Price Kerfoot, MD EdM
VA Boston Healthcare System, Harvard Medical School
United States: Institutional Review Board
|Veterans Affairs Boston Healthcare System||Boston, Massachusetts 02130|